pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
CTT-1403
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Cancer Targeted Technology LLC
0
catalysts
Phase 1
CTX-10726
Endometrial Cancer
$COMP
Compass, Inc.
0
catalysts
Phase 1
CTX-8371
Head And Neck Squamous Cell Carcinoma (HNSC)
$COMP
Compass, Inc.
0
catalysts
Phase 2
← prev
page 16 of 62
next →
131
Pain
89
Neurology
1
CUE-101
Human Papillomavirus (HPV) Associated Cancer
$CUE
Cue Biopharma, Inc.
0
catalysts
Phase 1
CUE-102
Gastric Cancer
$CUE
Cue Biopharma, Inc.
0
catalysts
Phase 1
CUSP-06
Ovarian Cancer
OnCusp Therapeutics Inc
0
catalysts
Phase 1
CX-801
Head And Neck Squamous Cell Carcinoma (HNSC)
$CTMX
CytomX Therapeutics, Inc.
0
catalysts
Preclinical
CXR-102
Squamous Non-Small Cell Lung Carcinoma
CorriXR Therapeutics Inc
0
catalysts
Preclinical
CYT-102
Recurrent Glioblastoma Multiforme (GBM)
Cytea Bio
0
catalysts
Marketed
Camptosar
Camptosar (irinotecan hydrochloride)
Colorectal Cancer
$PFE
PFIZER INC
0
catalysts
Phase 2
Cancer Program
Metastatic Colorectal Cancer
Programmed cell death protein 1
Mirror Biologics Inc
0
catalysts
Phase 1
Cantrixil
Epithelial Ovarian Cancer
Vivesto AB
0
catalysts
Phase 2
Carboxyamidotriazole Orotate
Pravitinib
Glioblastoma Multiforme (GBM)
Tactical Therapeutics Inc
0
catalysts
Phase 2
Cellular Immunotherapy for Metastatic Melanoma, Peritoneal Cancer, Fallopian Tube Cancer and Epithelial Ovarian Cancer
Metastatic Melanoma
The Chaim Sheba Medical Center
0
catalysts
Phase 1
Central Memory-Enriched T Cells
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
City of Hope
0
catalysts
Preclinical
Culnexin Inhibitors
Triple-Negative Breast Cancer (TNBC)
Culnexin Therapeutics LLC
0
catalysts
Phase 2
Cytokine-Induced Memory-Like Natural Killer Cells (CIML-NK)
Refractory Acute Myeloid Leukemia
Cincinnati Children's Hospital Medical Center
0
catalysts
Phase 2
D2C7-IT
Glioblastoma Multiforme (GBM)
Istari Oncology Inc
0
catalysts
Phase 1
D3L-001
Gastric Cancer
D3 Bio Inc
0
catalysts
Phase 2
D3S-002
Non-Small Cell Lung Cancer
D3 Bio Inc
0
catalysts
Phase 1
D3S-003
Solid Tumor
D3 Bio Inc
0
catalysts
Phase 1
DAC-002
Small-Cell Lung Cancer
Hangzhou DAC Biotech Co Ltd
0
catalysts
Phase 1
DAY-301
Adenocarcinoma Of The Gastroesophageal Junction
$DAWN
Day One Biopharmaceuticals, Inc.
0
catalysts
Phase 2
DB-1310
Metastatic Breast Cancer
Duality Biotherapeutics Inc
0
catalysts
Phase 2
DB-1311
Esophageal Squamous Cell Carcinoma (ESCC)
$BNTX
BioNTech SE
0
catalysts
Phase 1
DB-1317
Gastric Cancer
Duality Biotherapeutics Inc
0
catalysts
Phase 2
DB-1324
Gastrointestinal Tumor
Duality Biotherapeutics Inc
0
catalysts
Phase 2
DB-1418
Head And Neck Squamous Cell Carcinoma (HNSC)
Avenzo Therapeutics Inc
0
catalysts
Phase 2
DB-1419
Esophageal Squamous Cell Carcinoma (ESCC)
Duality Biotherapeutics Inc
0
catalysts
Phase 1
DCC-2812
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Deciphera Pharmaceuticals Inc
0
catalysts
